Doesn't fuss me actually
I am only focussed on the bottom line NPAT come report time, and EPS.
I have previously stated I hold the opinion that with roll-ups EBITDA might be a key acquisition metric, but for market valuation purposes we need to see efficient fall of earnings to NPAT and EPS.
Cheers
Gosouth
- Forums
- ASX - By Stock
- HLA
- Ann: HEALTHIA ANNOUNCES NEW QLD AND VIC GROWTH ACQUISITIONS
Ann: HEALTHIA ANNOUNCES NEW QLD AND VIC GROWTH ACQUISITIONS, page-19
Featured News
Add HLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online